Zobrazeno 1 - 3 of 3 pro vyhledávání: '"Michael Marcel Lederman"'
1
Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII
Autor: Mark T. Reding, Ingrid Pabinger, M. E. Eyster, Mingjun Wang, H. J. Shin, Michael Marcel Lederman, R. Walsch, M. Hardtke, Lone Hvitfeldt Poulsen, Lisa A. Michaels, Heng Joo Ng
Publikováno v: Reding, M T, Ng, H J, Poulsen, L H, Eyster, M E, Pabinger, I, Shin, H-J, Walsch, R, Lederman, M, Wang, M, Hardtke, M & Michaels, L A 2017, ' Safety and Efficacy of BAY 94-9027, a Prolonged-Half-Life Factor VIII ', Journal of Thrombosis and Haemostasis, vol. 15, no. 3, pp. 411-419 . https://doi.org/10.1111/jth.13597
BACKGROUND: BAY 94-9027 is a B-domain-deleted prolonged-half-life recombinant factor VIII (FVIII) conjugates in a site-specific manner with polyethylene glycol. OBJECTIVE: Assess efficacy and safety of BAY 94-9027 for prophylaxis and treatment of ble
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af9e38b5776a9062fc656696a5f8f150
https://doi.org/10.1111/jth.13597
Zobrazit plný text záznamu
2
Human immunodeficiency virus type 1 activation after blood transfusion
Autor: Daniel L. Georges, S. Bae, B. Yen-Lieberman, W. A. O'Brien, P. M. Mudido, D. Dorazio, J. Spritzler, Michael Marcel Lederman
Publikováno v: Transfusion. 36(10)
Background: Anemia and transfusion are predictors of disease progression in AIDS patients. This study was designed to examine the effects of blood transfusion on human immunodeficiency virus type 1 (HIV-1) expression. Study Design and Methods: Assays
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc3447e579bb310e3682022cf524f79f
https://pubmed.ncbi.nlm.nih.gov/8863771
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje